Incidence and predictors of anticipatory nausea and vomiting in Asia Pacific clinical practice—a longitudinal analysis

Supportive Care in Cancer

Volumn 23, Issue 1, 2015, Pages 283-291

  Chan, Alexandre ^a   Kim, Hoon Kyo ^b   Hsieh, Ruey Kuen ^c   Yu, Shiying ^d   de Lima Lopes, Gilberto ^e   Su, Wu Chou ^f   Baños, Ana ^g   Bhatia, Sandeep ^h   Burke, Thomas A ^h   Keefe, Dorothy M K ⁱ  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b The Catholic University of Korea   (South Korea)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e Johns Hopkins Singapore   (Singapore)

^f NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^g OptumInsight   (Sweden)

^h MERCK RESEARCH LABORATORIES   (United States)

ⁱ UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Anticipatory nausea; Anticipatory vomiting; Anxiety; Cancer; Chemotherapy; Observational

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANTICIPATORY NAUSEA AND VOMITING; ANXIETY; ARTICLE; ASIA; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CLINICAL PRACTICE; FEMALE; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAUSEA; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING; CHEMICALLY INDUCED; CLINICAL TRIAL; MULTICENTER STUDY; NEOPLASMS; QUESTIONNAIRE; STATISTICAL MODEL; VOMITING, ANTICIPATORY;

AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; ASIA; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; PROSPECTIVE STUDIES; QUESTIONNAIRES; VOMITING; VOMITING, ANTICIPATORY;

EID: 84919384932     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2375-0     Document Type: Article

References (22)

1. Aapro MS, Molassiotis A, Olver I (2005) Anticipatory nausea and vomiting. Support Care Cancer 13(2):117–121
2. Roscoe JA, Morrow GR, Aapro MS, Molassiotis A, Olver I (2011) Anticipatory nausea and vomiting. Support Care Cancer 19(10):1533–1538. doi:10.1007/s00520-010-0980-0
3. Kamen C, Tejani MA, Chandwani K, Janelsins M, Peoples AR, Roscoe JA, Morrow GR (2014) Anticipatory nausea and vomiting due to chemotherapy. Eur J Pharmacol 722:172–179. doi:10.1016/j.ejphar.2013.09.071
4. Morrow GR, Roscoe JA, Kirshner JJ, Hynes HE, Rosenbluth RJ (1998) Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics. Support Care Cancer 6(3):244–247
5. Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21(Suppl 5):v232–v243. doi:10.1093/annonc/mdq194
6. National Comprehensive Cancer Network (2013) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): antiemesis, Version I.2014. http://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf. Accessed 24 Feb 2014
7. Multinational Association of Supportive Care in Cancer (MASCC) (2013) MASCC/ESMO Antiemetic guideline 2013. http://www.mascc.org/assets/documents/mascc_guidelines_english_2013.pdf. Accessed 24 Feb 2014
8. Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B, Morrow G, Rao KV, Schwartz RN, Lyman GH (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29(31):4189–4198. doi:10.1200/JCO.2010.34.4614
9. Keefe D, Chan A, Kim H-K, Hsieh R-K, Yu S, Wang YC, Nicholls R, Burke TA (2014) Rationale and design of the Pan Australasian ChemoTherapy InduCed Emesis burden of illness study. Support Care Cancer: under consideration
10. Molassiotis A, Coventry PA, Stricker CT, Clements C, Eaby B, Velders L, Rittenberg C, Gralla RJ (2007) Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool. J Pain Symptom Manag 34(2):148–159
11. Hsieh R-K, Chan A, Kim H-K, Yu S, Kim J-G, Lee M-A, Dalén J, Jung H, Chung J-M, Burke TA, Keefe D (2014) The incidence of chemotherapy-induced nausea and vomiting within and across Asia Pacific countries following moderately and highly emetogenic chemotherapy. Support Care Cancer: under consideration
12. Wilcox PM, Fetting JH, Nettesheim KM, Abeloff MD (1982) Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma. Cancer Treat Rep 66(8):1601–1604
13. Watson M, McCarron J, Law M (1992) Anticipatory nausea and emesis, and psychological morbidity: assessment of prevalence among out-patients on mild to moderate chemotherapy regimens. Br J Cancer 66(5):862–866
14. Aapro MS, Kirchner V, Terrey JP (1994) The incidence of anticipatory nausea and vomiting after repeat cycle chemotherapy: the effect of granisetron. Br J Cancer 69(5):957–960
15. Morrow GR, Roscoe JA, Hynes HE, Flynn PJ, Pierce HI, Burish T (1998) Progress in reducing anticipatory nausea and vomiting: a study of community practice. Support Care Cancer 6(1):46–50
16. Yap KY, Low XH, Chui WK, Chan A (2012) Computational prediction of state anxiety in Asian patients with cancer susceptible to chemotherapy-induced nausea and vomiting. J Clin Psychopharmacol 32(2):207–217. doi:10.1097/JCP.0b013e31824888a1
17. Montgomery GH, Tomoyasu N, Bovbjerg DH, Andrykowski MA, Currie VE, Jacobsen PB, Redd WH (1998) Patients’ pretreatment expectations of chemotherapy-related nausea are an independent predictor of anticipatory nausea. Ann Behav Med 20(2):104–109
18. Kim Y, Morrow GR (2007) The effects of family support, anxiety, and post-treatment nausea on the development of anticipatory nausea: a latent growth model. J Pain Symptom Manag 34(3):265–276. doi:10.1016/j.jpainsymman.2006.11.014
19. Hickok JT, Roscoe JA, Morrow GR (2001) The role of patients’ expectations in the development of anticipatory nausea related to chemotherapy for cancer. J Pain Symptom Manag 22(4):843–850
20. Roscoe JA, Hickok JT, Morrow GR (2000) Patient expectations as predictor of chemotherapy-induced nausea. Ann Behav Med 22(2):121–126
21. Rhodes VA, Watson PM, McDaniel RW, Hanson BM, Johnson MH (1995) Expectation and occurrence of postchemotherapy side effects: nausea and vomiting. Cancer Pract 3(4):247–253
22. Dong S, Yu S (2013) Status survey on chemotherapy-induced nausea and vomiting. Chin J Evid-Based Med 13(6):687–691. doi:10.7507/1672-2531.20130122. In Chinese